These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27916566)

  • 1. Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines.
    Kim OY; Lee J; Gho YS
    Semin Cell Dev Biol; 2017 Jul; 67():74-82. PubMed ID: 27916566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicle-Mimetic Ghost Nanovesicles for Delivering Anti-Inflammatory Drugs to Mitigate Gram-Negative Bacterial Outer Membrane Vesicle-Induced Systemic Inflammatory Response Syndrome.
    Go G; Lee J; Choi DS; Kim SS; Gho YS
    Adv Healthc Mater; 2019 Feb; 8(4):e1801082. PubMed ID: 30549424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Ghosts: Biomimetic membranal vesicles, technology and characterization.
    Oieni J; Levy L; Letko Khait N; Yosef L; Schoen B; Fliman M; Shalom-Luxenburg H; Malkah Dayan N; D'Atri D; Cohen Anavy N; Machluf M
    Methods; 2020 May; 177():126-134. PubMed ID: 31794834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomimetic Acoustically-Responsive Vesicles for Theranostic Applications.
    Hsieh CC; Kang ST; Lin YH; Ho YJ; Wang CH; Yeh CK; Chang CW
    Theranostics; 2015; 5(11):1264-74. PubMed ID: 26379791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gram-negative and Gram-positive bacterial extracellular vesicles.
    Kim JH; Lee J; Park J; Gho YS
    Semin Cell Dev Biol; 2015 Apr; 40():97-104. PubMed ID: 25704309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward.
    Zhang YF; Shi JB; Li C
    Cytotherapy; 2019 Nov; 21(11):1122-1136. PubMed ID: 31699595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome mimetics: a novel class of drug delivery systems.
    Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
    Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems.
    Ohno S; Drummen GP; Kuroda M
    Int J Mol Sci; 2016 Feb; 17(2):172. PubMed ID: 26861303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
    Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
    Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loading of Extracellular Vesicles with Hydrophobically Modified siRNAs.
    Didiot MC; Haraszti RA; Aronin N; Khvorova A
    Methods Mol Biol; 2018; 1740():199-214. PubMed ID: 29388146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging prospects of extracellular vesicles for brain disease theranostics.
    Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
    J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles in cardiovascular disease.
    Huang C; Neupane YR; Lim XC; Shekhani R; Czarny B; Wacker MG; Pastorin G; Wang JW
    Adv Clin Chem; 2021; 103():47-95. PubMed ID: 34229852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Delivery with Extracellular Vesicles: From Imagination to Innovation.
    de Jong OG; Kooijmans SAA; Murphy DE; Jiang L; Evers MJW; Sluijter JPG; Vader P; Schiffelers RM
    Acc Chem Res; 2019 Jul; 52(7):1761-1770. PubMed ID: 31181910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treg-Derived Extracellular Vesicles: Roles in Diseases and Theranostics.
    Wu T; Wang L; Gao C; Jian C; Liu Y; Fu Z; Shi C
    Mol Pharm; 2024 Jun; 21(6):2659-2672. PubMed ID: 38695194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.